2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$23.11-$0.07 (-0.28%)
Price as of Jun 23, 2026 7:58 PM EDT- $11.9BMarket Cap
- 79.03%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$23.11-$0.07 (-0.28%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.7B +6.22% | 4.4B +0.50% | 4.4B +0.14% | 4.4B -7.43% | |
Cost of Revenue | 2.1B +5.94% | 2.0B +3.73% | 1.9B +0.94% | 1.9B -10.36% | |
Gross Profit | 2.6B +6.44% | 2.4B -2.01% | 2.5B -0.48% | 2.5B -5.06% | |
Sales and Marketing Expense | 1.4B +8.83% | 1.3B +2.26% | 1.3B +1.58% | 1.3B -9.90% | |
Research and Development Expense | -368.0M +6.98% | -344.0M +5.20% | -327.0M +1.87% | -321.0M -13.01% | |
Depreciation and Amortization Expense | 680.0M +2.72% | 662.0M -4.61% | 694.0M +1.76% | 682.0M -4.75% | |
Total Operating Expenses | 2.1B -46.29% | 4.0B -29.60% | 5.6B +25.18% | 4.5B -15.92% | |
Operating Profit | -224.0M -145.90% | 488.0M +140.84% | -1.2B +1,559.72% | -72.0M -87.30% | |
Interest Income | 43.0M +38.71% | 31.0M +244.44% | 9.0M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -277.0M +14.94% | -241.0M +2.12% | |
Interest Income and Expense and Net | 43.0M +38.71% | 31.0M +111.57% | -268.0M +11.20% | -241.0M +2.12% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | -75.0M +134.38% | -32.0M +540.00% | |
Income before Taxes | -224.0M -145.90% | 488.0M +140.84% | -1.2B +1,559.72% | -72.0M -87.30% | |
Income Taxes | 8.0M -94.67% | 150.0M +316.67% | 36.0M +500.00% | 6.0M +106.32% | |
Extraordinary Items | 71.0M N/A | N/A N/A | 26.0M N/A | N/A N/A | |
Net Income | -232.0M -168.64% | 338.0M +127.46% | -1.2B +1,478.21% | -78.0M -83.47% | |
Net Income from Continuing Operations Applicable to Common | -224.0M -145.90% | 488.0M +140.84% | -1.2B +1,559.72% | -72.0M -87.30% | |
Basic EPS and Net Income | -0.47 -169.12% | 0.68 +127.20% | -2.50 +1,462.50% | -0.16 -83.51% | |
Diluted EPS and Net Income | -0.47 -169.12% | 0.68 +127.20% | -2.50 +1,462.50% | -0.16 -83.51% | |
Basic Weighted Average Shares | 496.4M +0.49% | 494.0M +0.35% | 492.3M +0.82% | 488.3M +0.23% | |
Diluted Weighted Average Shares | 496.4M -0.18% | 497.3M +1.02% | 492.3M +0.82% | 488.3M +0.23% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 545.0M +16.45% | 468.0M +32.95% | 352.0M +2.03% | 345.0M -45.92% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 545.0M +16.45% | 468.0M +32.95% | 352.0M +2.03% | 345.0M -45.92% | |
Total Current Assets | 3.5B +7.56% | 3.2B -5.64% | 3.4B +3.90% | 3.3B +0.09% | |
Accumulated Depreciation | 952.0M +10.96% | 858.0M +5.28% | 815.0M +12.72% | 723.0M -30.55% | |
Property and Plant and Equipment and Net | 1.4B +41.89% | 993.0M -3.22% | 1.0B +2.70% | 999.0M -5.84% | |
Total Long-Term Assets | 304.0M -2.25% | 311.0M -8.80% | 341.0M -9.79% | 378.0M -2.33% | |
Total Assets | 13.4B +5.90% | 12.6B -12.17% | 14.4B -7.29% | 15.5B -6.02% | |
Income Taxes Payable | 382.0M -14.92% | 449.0M -20.81% | 567.0M -14.35% | 662.0M -11.14% | |
Total Short-Term Debt | 74.0M +68.18% | 44.0M +15.79% | 38.0M -90.21% | 388.0M +31.97% | |
Total Current Liabilities | 1.6B +21.44% | 1.3B +5.96% | 1.2B -27.09% | 1.7B +3.59% | |
Total Long-Term Debt | 3.9B -7.81% | 4.3B -25.44% | 5.7B +5.29% | 5.4B -9.58% | |
Total Long-Term Liabilities | 427.0M +41.39% | 302.0M -26.52% | 411.0M +79.48% | 229.0M -12.26% | |
Total Liabilities | 6.8B +4.50% | 6.5B -19.92% | 8.1B -0.77% | 8.2B -8.31% | |
Retained Earnings | -2.2B +11.90% | -1.9B -14.77% | -2.3B +116.46% | -1.1B +11.38% | |
Total Stockholders Equity | 6.5B +7.40% | 6.1B -2.04% | 6.2B -14.62% | 7.3B -3.30% | |
Total Shares Outstanding | 497.0M +0.51% | 494.4M +0.32% | 492.8M +3.92% | 474.2M +0.24% | |
Cash Flow | |||||
Cash from Operating Activities | 560.0M +3.51% | 541.0M +99.63% | 271.0M -40.04% | 452.0M -6.42% | |
Capital Expenditures | 276.0M +87.76% | 147.0M +5.00% | 140.0M +2.19% | 137.0M +8.73% | |
Cash from Investing Activities | -279.0M -124.09% | 1.2B +785.21% | -169.0M -5.59% | -179.0M -66.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -275.0M -81.57% | -1.5B +1,697.59% | -83.0M -84.88% | -549.0M -361.43% | |
Financials Ratio | |||||
Gross Margin | 54.99% +0.21% | 54.88% -2.50% | 56.28% -0.62% | 56.63% +2.56% | |
Operating Margin | -4.75% -143.21% | 10.99% +140.63% | -27.05% +1,557.45% | -1.63% -86.28% | |
Return on Assets | -1.79% -171.29% | 2.51% +130.39% | -8.25% +1,590.33% | -0.49% -82.34% | |
Return on Equity | -3.67% -166.88% | 5.49% +130.12% | -18.22% +1,631.85% | -1.05% -82.15% | |
Revenue Growth | 6.22% +1,148.26% | 0.50% +266.25% | 0.14% +101.83% | -7.43% -116.30% | |
Current Ratio | 2.17 -11.44% | 2.44 -10.95% | 2.75 +42.50% | 1.93 -3.38% | |
Cash Ratio | 0.34 -4.10% | 0.36 +25.49% | 0.28 +39.91% | 0.20 -47.80% | |
Debt-to-Equity Ratio | 0.61 -13.43% | 0.71 -23.60% | 0.93 +15.87% | 0.80 -4.49% | |
Debt-to-Assets Ratio | 0.30 -12.23% | 0.34 -14.78% | 0.40 +6.72% | 0.38 -1.75% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow